Has William Erber, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,372 in general payments to William Erber, MD across 108 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Erber, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Erber, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Erber, MD

Gastroenterology · Brooklyn, NYNPI 1588661052

Payments from drug & device makers

$7,372in general payments, 2019–2025

Across 108 payments — averaging $68.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Olympus America Inc.$5K
Takeda Pharmaceuticals U.S.A., Inc.$312
AbbVie$310
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$294
Gilead$293
Johnson & Johnson$265
plus $724 from 15 others

What the payments were for

Food & beverage$2,17029%
Education$270%
Other$5,17570%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Olympus America Inc.	4	$5,175
Takeda Pharmaceuticals U.S.A., Inc.	16	$312
AbbVie	13	$310
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	16	$294
Gilead	14	$293
Johnson & Johnson	12	$265
UCB, Inc.	5	$90
Phathom Pharmaceuticals, Inc.	5	$89
Madrigal Pharmaceuticals	3	$78
Pfizer	4	$64
QOL Medical, LLC	2	$62
Ardelyx, Inc.	2	$60
Merck	2	$51
Bristol Myers Squibb	2	$46
Intercept Pharmaceuticals, Inc.	2	$32
Vivus LLC	1	$28
Amgen	1	$28
Celltrion USA Inc.	1	$27
Lilly USA, LLC	1	$27
Regeneron Healthcare Solutions, Inc.	1	$23
Braintree Laboratories, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DISPOSABLE BIOPSY FORCEPS$3,309
EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE$1,787
EVIS EXERA lll COLONOVIDEOSCOPE$1,317

How this compares

$7,372 in reported general payments places this provider in the 70th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Medicare billing

Part B allowed, 2024

$13,083

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	22	$217

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Brooklyn

Igor GrosmanBrooklyn$2.8M
Alexander BrunBrooklyn$505K
Kevin TinBrooklyn$369K
Sam MoskowitzBrooklyn$332K
Michael GerdisYonkers$11.9M
David HudesmanNew York$3.6M
Ellen ScherlNew York$2.9M
Bruce SandsNew York$2.8M
Arun SwaminathNew York$2.7M
Sonal KumarNew York$2.3M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →